OncoLink Cancer Treatment and Resources
OncoLink Cancer Treatment and Resources
Link to OncoLink

Survival Rates Of Prostate Cancer When Treated With And Without External Beam Radiation And Seeds

Richard Whittington, MD
Ultima Vez Modificado: 1 de noviembre del 2001

Question
Dear OncoLink "Ask the Experts,"
My father was just diagnosed with prostate cancer and the impression is it's still in the early stage but aggressive. Radical prostatectomy is not recommended due to his past medical history. My father is 57 years old and re-occurrence rate is of major concern. His PSA level was 4, but the Gleason score was 7. I would like to know what are the survival and re-occurrence rates of external beam radiation and external beam radiation used together with radioactive seeds.  
Thank you for your time and consideration.
NB


Answer
Richard Whittington, MD, Associate Professor of Radiation Oncology at the University of Pennsylvania School of Medicine, responds:

First off, this would not be considered an extremely aggressive tumor with a Gleason Score 7 and a PSA of 4.0. However, it can have about a 50% mortality rate at 10 years. The experience with external radiation +/- seeds is very operator dependant. With a dose of 66 to 70 Gy (6600-7000 rads), the overall 15-year survival rate (free of tumor) is about 60%; with doses of 74 to 78 Gy, the rate may rise to 75 to 80%.

External radiation with seeds is associated with a 60% 5-year disease free survival. Some others have even reported that it may be as high as 90% at 5 years in very select patients. There is a trial that shows that the addition of hormones to external radiation, for 6 to 12 months, will increase the standard cure rates by up to 20%. Our experience with adding hormones to seeds is that is that it also raises the 5 yr disease free survival into the upper 80% range. The key is to go to a center that sees a substantial number of men with prostate cancer each year, as experience is very helpful.

OncoLink I wish u knew...

Ms. Sherry discusses how the experience of caring for patients with advanced lung cancer has changed her life. Read more.

Cancer Types
Bone Cancer
Brain Tumors
Breast Cancer
Carcinoid Tumors
Endocrine System Cancers
Gastrointestinal Cancers
Gynecologic Cancers
Head and Neck Cancers
Leukemia
Lung Cancers
Lymphomas
Myelomas
Pediatric Cancers
Penile Cancer
Prostate Cancer
Sarcomas
Skin Cancers
Testicular Cancer
Thyroid Cancer
Urinary Tract Cancers
OncoLink Vet

Cancer Treatment
Biologic Therapy
Bone Marrow Transplants
Chemotherapy

Clinical Trials
Complementary Medicine
Gene Therapy
General Treatment Concerns
Hormone Therapy
PDT Center
Proton Therapy
Radiation Oncology
Surgical Oncology
Targeted Therapies
Vaccine Therapies

Cancer Support
Caregivers
Hospice Care and Bereavement
Nutrition and Cancer
Sexuality & Fertility
Side Effects
Support
Survivorship
Exercise and Cancer

Cancer Resources
Cancer News
OncoLink University
Nurses' Notes
Conferences
Newly Diagnosed Patients
Causes and Prevention
Legal and Financial Information for Patients
LGBT Resources
NCI Resources
Global Resources
Cancer Resource List
Resources for Young Adults

OncoLink Media Library
OncoLink TV
Book, Music and Video Reviews


Ask the Experts
Brown Bag Chat
Tracy's Corner

About OncoLink
About OncoLink
Giving to OncoLink
Contact Information
Usage Policy
Editorial Board
How to Partner with OncoLink
Link to OncoLink
Mission Statement

OncoLink Cancer Resources RSS What's New RSS